Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis

被引:53
|
作者
Alcázar, A
Regidor, I
Masjuan, J
Salinas, M
Alvarez-Cermeño, JC
机构
[1] Hosp Ramon & Cajal, Serv Neurol, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Serv Bioquim Invest, E-28034 Madrid, Spain
[3] Univ Alcala de Henares, Dept Med, Alcala De Henares, Spain
关键词
apoptosis; axonal damage; cerebrospinal fluid; cultured neurons; multiple sclerosis;
D O I
10.1016/S0165-5728(99)00225-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The importance of axonal damage in multiple sclerosis (MS) has been recently stressed in proton magnetic resonance spectroscopy and pathological studies, but the exact mechanism producing this damage is unknown. The aim of our study was to ascertain whether soluble mediators present in the cerebrospinal fluid (CSF) of patients with relapsing-remitting MS could induce neuron injury in culture. Different biochemical and cytochemical parameters were determined in primary embryonal rat neuron cultures following 8 days of exposure to CSF. Cytotoxic activity was evaluated with a blue formazan production colorimetric assay. Morphological and immunocytochemical studies performed with antibodies against beta-tubulin revealed neuritic fragmentation, axonal damage and cellular shrinkage indicating apoptosis, Detection of apoptosis was carried out using the fluorescent DNA-binding dye Hoechst 33342, as well as by a Terminal deoxynucleotidyl transferase-mediated dUTP Nick End-Labeling assay. We observed that soluble factors in CSF from patients with "aggressive" MS i.e, those with poor recovery after relapses, induced neurite breakdown and neuronal apoptosis in cultures. Neuron injury is not related with blood-brain barrier dysfunction nor with IgG index. Interestingly, CSF from patients with "non-aggressive" MS i.e., relapsing-remitting patients with a good recovery after relapses, did not induce any damage. In conclusion, we report that CSF from patients with aggressive MS bears soluble mediators that induce axonal damage and apoptosis of neurons in culture. These mediators can be present during the first attack of the disease, and the neuronal damage caused could be related to the functional deficit of these MS patients. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 50 条
  • [41] Relapsing-remitting tumefactive multiple sclerosis
    Selkirk, SM
    Shi, J
    MULTIPLE SCLEROSIS, 2005, 11 (06): : 731 - 734
  • [42] Autohemotherapy for relapsing-remitting multiple sclerosis
    Mubaidin, AF
    Horani, KA
    Dehayyat, MA
    Shehab, M
    Abu-Ruman, IA
    Shurbaji, AA
    Kurdi, A
    Hiari, M
    Khakish, M
    Harahsheh, O
    Dabbas, M
    NEUROLOGY, 2001, 56 (08) : A75 - A75
  • [43] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Guo, Rui
    Zhang, Fubo
    Zhang, Chao
    Dong, Shuai
    Zhou, Hongyu
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [44] A retrospective analysis in patients with relapsing-remitting multiple sclerosis
    Maeurer, Mathias
    Lang, Michael
    Elias, Wolfgang
    Ries, Stefan
    Reifschneider, Stefan
    Kaefferlein, Wolfgang
    Windhagen, Susanne
    Wensdoerfer, Colin
    Niemczyk, Gabriele
    Schikhnaier, Petra
    Schwab, Stefan
    MULTIPLE SCLEROSIS, 2008, 14 : S164 - S165
  • [45] Serum neurofilament in patients with relapsing-remitting multiple sclerosis
    Brandt, A. U.
    Paul, F.
    Freing, A.
    Oberwahrenbrock, T.
    Petzold, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S269 - S270
  • [46] Vestibular rehabilitation in patients with relapsing-remitting multiple sclerosis
    Pavan, Karina
    Marangoni, Bruna E. M.
    Schmidt, Kizi B.
    Cobe, Femanda A.
    Matuti, Gabriela S.
    Nishino, Lucia K.
    Thomaz, Rodrigo B.
    Mendes, Maria Fernanda
    Lianza, Sergio
    Tilbery, Charles Peter
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (2A) : 332 - 335
  • [47] Rituximab in relapsing-remitting multiple sclerosis
    Schrijver, Hans M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24): : 2645 - 2645
  • [48] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [49] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [50] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):